申请人:3M Innovative Properties Company
公开号:US20040014754A1
公开(公告)日:2004-01-22
Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain urea, thiourea, acylurea, or sulfonylurea functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.
在1位置含有脲、硫脲、酰基脲或磺酰脲官能团的咪唑喹啉和四氢咪唑喹啉化合物可用作免疫反应修饰剂。该发明的化合物和组合物可以诱导各种细胞因子的生物合成,可用于治疗包括病毒性疾病和肿瘤性疾病在内的多种疾病。